Telomir Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense
Telomir Pharmaceuticals, Inc. (TELO) reported Share-based Payment Arrangement, Expense of $198.73 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-13
- Telomir Pharmaceuticals, Inc. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $198.73K, a 95.74% decline year-over-year.
- Telomir Pharmaceuticals, Inc. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $39.80B, a 97.11% decline year-over-year.
- Telomir Pharmaceuticals, Inc. share-based payment arrangement, expense for the quarter ending 2025-06-30 was $4.66M.
- Telomir Pharmaceuticals, Inc. share-based payment arrangement, expense for the quarter ending 2025-03-31 was $1.38T.
- Telomir Pharmaceuticals, Inc. share-based payment arrangement, expense for fiscal 2025 was $5.30M, a 23.19% decline from fiscal 2024.
- Telomir Pharmaceuticals, Inc. share-based payment arrangement, expense for fiscal 2024 was $6.90M.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 6 month as first filed | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $198.73K 10-Q · filed 2026-08-13 | $238.54K 10-Q · filed 2026-08-13 | |||
| 2026-03-31 | $39.80B 10-Q · filed 2026-05-14 | ||||
| 2025-12-31 | $5.30M 10-K · filed 2026-03-17 | ||||
| 2025-06-30 | $4.66M 10-Q · filed 2026-08-13 | $6.04M 10-Q · filed 2026-08-13 | $6.00M 10-Q · filed 2025-08-14 | ||
| 2025-03-31 | $1.38T 10-Q · filed 2026-05-14 | $1.40M 10-Q · filed 2025-05-14 | |||
| 2024-12-31 | $6.90M 10-K · filed 2026-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |